Skip to main content
Annals of Intensive Care
Fig. 2 | Annals of Intensive Care

Fig. 2

From: Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial

Fig. 2

Participant and analysis population flow chart. CE clinically evaluable, CV-SOFA cardiovascular SOFA component score, ITT intention-to-treat, LRT lower respiratory tract, mITT microbiologic intention-to-treat, R-SOFA respiratory SOFA component score, SOFA Sequential Organ Failure Assessment

Back to article page